Yumiko Akamine (Y Akamine)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Oral Anticoagulants

Chronic Myeloid Leukemia

Top Venues

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yumiko Akamine, Yuka Kikuchi, Masatomo Miura
Effects on monotherapy and reduction of antipsychotic drugs by clozapine therapy in Japanese patients with treatment-resistant schizophrenia. Journal of clinical pharmacy and therapeutics 46 (5) (2021)
Yumiko Akamine, Nobuhiro Fujiyama, Hideaki Kagaya, Mitsuru Saito, Hiroshi Miura, Yukihiro Terada, Tsutomu Takahashi, Shigeru Satoh, Masatomo Miura
Tacrolimus concentrations after renal transplantation in a mother-neonate dyad: Maternal, neonatal and breast milk measurements. Journal of clinical pharmacy and therapeutics 46 (6) (2021)
Maiko Abumiya, Yumiko Akamine, Shiori Sato, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Naoto Takahashi, Masatomo Miura
Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia. Journal of clinical pharmacy and therapeutics 46 (2) (2020)
Hironobu Yagishita, Shinichiro Minami, Yumiko Akamine, Shotaro Kato, Katsunori Iijima, Masatomo Miura
Drug interactions between warfarin and lenvatinib in a patient with the CYP2C9*1/*3 and VKORC1-1639G/A genotype. Journal of clinical pharmacy and therapeutics 44 (6) (2019)
Yumiko Akamine, S Sato, H Kagaya, T Ohkubo, S Satoh, M Miura
Comparison of electrochemiluminescence immunoassay and latex agglutination turbidimetric immunoassay for evaluation of everolimus blood concentrations in renal transplant patients. Journal of clinical pharmacy and therapeutics 43 (5) (2018)
Yumiko Akamine, Hideaki Kagaya, Tadashi Ohkubo, Shigeru Satoh, Masatomo Miura
A comparison of the effects of CYP3A5 polymorphism on tacrolimus blood concentrations measured by 4 immunoassay methods in renal transplant patients. Journal of clinical pharmacy and therapeutics 43 (2) (2017)